Business Information
The group's principal activities are to manufacture, develop and market medical technology and provide device-based medical therapies. The group provides lifelong solutions for people with chronic disease. The products developed are used for treating heart failure, coronary and peripheral vascular disease, heart valve replacement, malignant and non-malignant pain and other heart related disorders. It also offers therapeutic and diagnostic devices used for the treatment of diabetes, neurological, gastroenterological, urological, and movement disorders, spinal and neurosurgery, neurodegenerative disorders and ear, nose and throat (ent) surgery. They are used by the medical specialists including electrophysiologist, implanting cardiologists and cardiovascular surgeons. Group operates in the United States, Europe, the Asia-Pacific and other foreign countries. In nov 2003, the group acquired vertelink corporation.
|
|
Name |
Title
|
Email
|
| Arthur Collins | Chmn. | N/A | | Gary Ellis | CFO, Sr. VP | N/A | | James Dallas | CIO, Sr. VP | N/A | | Michael Demane | COO | N/A | | William Hawkins | Dir., COO, Pres. | N/A |
|
|
Year |
Sales |
Net Income |
| 2004 | 9,087,200 | 1,959,300 | | 2005 | 10,054,600 | 1,803,900 | | 2006 | 11,292,000 | 2,546,700
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
